APLT Applied Therapeutics Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: APLT

Price (delayed)

$0.8449

Market cap

$40.65M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.18

Enterprise value

$24.89M

Applied Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need. The Company's lead drug candidate, ...

Highlights
The company's EPS rose by 47% YoY and by 34% QoQ
APLT's debt is down by 33% year-on-year and by 11% since the previous quarter
The equity has dropped by 94% year-on-year and by 58% since the previous quarter
The quick ratio has dropped by 70% year-on-year and by 11% since the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://www.appliedtherapeutics.com
Peers: OVID

Key stats

What are the main financial stats of APLT
Market
Shares outstanding
48.11M
Market cap
$40.65M
Enterprise value
$24.89M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
10
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$82.51M
EBITDA
-$82.07M
Free cash flow
-$78.09M
Per share
EPS
-$2.18
Free cash flow per share
-$2.06
Book value per share
$0.08
Revenue per share
$0
TBVPS
$1.01
Balance sheet
Total assets
$38.36M
Total liabilities
$34.3M
Debt
$891,000
Equity
$4.06M
Working capital
$3.88M
Liquidity
Debt to equity
0.22
Current ratio
1.12
Quick ratio
0.91
Net debt/EBITDA
0.19
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-138.6%
Return on equity
-405.1%
Return on invested capital
N/A
Return on capital employed
-1,670.5%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

APLT stock price

How has the Applied Therapeutics stock price performed over time
Intraday
0.57%
1 week
-5.57%
1 month
-14.66%
1 year
-62.11%
YTD
11.17%
QTD
11.17%

Financial performance

How have Applied Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$82.95M
Net income
-$82.51M
Gross margin
N/A
Net margin
N/A
The company's net income rose by 22% YoY and by 13% QoQ
Applied Therapeutics's operating income has increased by 21% YoY and by 9% from the previous quarter

Growth

What is Applied Therapeutics's growth rate over time

Valuation

What is Applied Therapeutics stock price valuation
P/E
N/A
P/B
10
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS rose by 47% YoY and by 34% QoQ
APLT's price to book (P/B) is 150% more than its last 4 quarters average of 4.0
The equity has dropped by 94% year-on-year and by 58% since the previous quarter

Efficiency

How efficient is Applied Therapeutics business performance
The return on assets has dropped by 65% year-on-year and by 5% since the previous quarter
The return on equity has declined by 49% since the previous quarter

Dividends

What is APLT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for APLT.

Financial health

How did Applied Therapeutics financials performed over time
The company's total assets is 12% higher than its total liabilities
The quick ratio has dropped by 70% year-on-year and by 11% since the previous quarter
The current ratio has plunged by 66% YoY and by 6% from the previous quarter
APLT's debt is 78% smaller than its equity
The company's debt to equity has surged by 120% QoQ
The equity has dropped by 94% year-on-year and by 58% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.